TABLE 1

Correlations of serum FGF21* levels with cardiometabolic risk factors

Serum FGF21
Serum FGF21 (age-adjusted)
Serum FGF21 (age-and BMI-adjusted)
rPrPrP
Age0.1680.010
BMI0.2000.0020.229<0.001
Waist circumference0.244<0.0010.249<0.0010.1350.041
Waist-to-hip ratio0.256<0.0010.236<0.0010.1610.014
Fat percentage0.2200.0100.2300.0070.1070.218
Fasting glucose0.0240.2010.1450.1360.1330.172
2-h glucose0.0380.6950.0500.6060.0450.648
Fasting insulin*0.2730.0010.2880.0010.1840.016
HOMA-IR*0.2920.0010.3040.0040.2050.087
QUICKI−0.2730.002−0.2810.002−0.1780.051
Free fatty acids*§0.0690.3650.0220.7730.0000.999
Triglycerides*§0.510<0.0010.485<0.0010.457<0.001
LDL cholesterol§0.1080.1030.0800.3000.0500.518
HDL cholesterol§−0.286<0.001−0.280<0.001−0.2500.001
Systolic blood pressure0.1810.0530.1680.0750.1390.143
Diastolic blood pressure0.0330.7290.0450.6360.0050.958
Serum A-FABP*0.327<0.0010.299<0.0010.2050.002
Serum hsCRP*0.1300.0700.1040.1490.0600.405
Serum adiponectin*−0.0980.141−0.1330.046−0.0870.195
  • *

    * Log transformed before analysis.

  • Included 63 men and 73 women with available data.

  • Included 63 men and 62 women not on diabetic treatment.

  • §

    § Included 94 men and 96 women not on lipid-lowering drug.

  • Included 62 men and 54 women not on antihypertensive drug.